As an effector of anti-inflammatory glucocorticoid signaling, ANXA1 has demonstrated an ability to suppress leukocyte inflammatory processes [187], limit microglial activation, improve microglial phagocytosis [188], restore BBB function and reduce tau phosphorylation in an AD rodent model [186]. The gene discussed is ANXA1; the disease is Alzheimer disease.